Fundsmith, an investment management firm based in London, has released its annual 2025 investor letter for its “Fundsmith ...

IDEXX Laboratories, Inc. (IDXX) is a multinational healthcare company specializing in the development, manufacture, and ...

Image quality comparison between ImageVue DR50 and ImageVue DR50 Plus Radiography is a standard diagnostic technique in ...

Since joining IDEXX in 2011, he has held senior positions across key portions of the Company's business, including ...

IDEXX Laboratories has designated Michael Erickson to succeed Jonathan Mazelsky at the helm of the pet healthcare company later this year.

IDEXX Laboratories, a leader in pet diagnostic and software products, is targeting 10%+ organic sales growth and 15-20% EPS growth, making it a high-quality company. The company is focusing on ...

The IDEXX Cancer Dx Panel has already transformed cancer screening for veterinarians. Today, more than 5,500 practices across ...

In the latest quarter, 4 analysts provided ratings for IDEXX Laboratories (NASDAQ:IDXX), showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, ...

If you are wondering whether IDEXX Laboratories is still fairly priced after a strong run, this article walks through what the current share price could mean for long term investors. The stock last ...

Palo Alto and IDEXX both gained during the Wednesday session, while Capital One Financial and the Materials Select Sector ...

While they might not represent the most exciting field in the biotech space, animal healthcare companies have been a steady, consistent source of growth in what's often a turbulent market. One company ...

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results. Third Quarter Results The Company ...